8,203 PACS Group (PACS) RSUs awarded to Chief Compliance Officer

Rhea-AI Filing Summary

Priegnitz Kelly reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received a grant of 8,203 restricted stock units of common stock. These RSUs vest in three substantially equal annual installments starting on March 24, 2026, and will deliver one share per unit at vesting. Following this award, Priegnitz directly holds 38,203 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Priegnitz Kelly

Role Chief Compliance Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,203	$0.00	--

Holdings After Transaction: Common Stock — 38,203 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Priegnitz Kelly

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		A		8,203(1)	A	$0	38,203	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PACS (PACS) report for Kelly Priegnitz?

Kelly Priegnitz, Chief Compliance Officer of PACS Group, Inc., received a grant of 8,203 restricted stock units of common stock. Each RSU converts into one share upon vesting, increasing her direct equity-based compensation stake in the company.

How many PACS Group shares does Kelly Priegnitz hold after this Form 4?

After this equity award, Kelly Priegnitz directly holds 38,203 shares of PACS Group common stock. This total includes the newly granted 8,203 restricted stock units, which will convert into shares as they vest over time.

What are the vesting terms of the 8,203 RSUs granted by PACS Group?

The 8,203 restricted stock units granted to Kelly Priegnitz vest in three substantially equal annual installments. Vesting occurs on the first, second, and third anniversaries of March 24, 2026, subject to her continued service through each vesting date.

Does the RSU grant to PACS Group’s CCO involve a purchase price?

No, the RSU grant to Kelly Priegnitz carries a transaction price of $0.0000 per share. RSUs are typically granted as part of compensation and convert into common shares upon vesting without requiring a purchase payment from the recipient.

Is the PACS Group Form 4 transaction a buy or a grant of shares?

The Form 4 reports an acquisition through a grant or award, not an open-market purchase. The transaction code is “A,” indicating a grant of restricted stock units as part of compensation rather than shares bought on the market.